Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00545233
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 155
Early research (Phase 1)Ended earlyNCT01586325
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 8
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableUnknownNCT04959643
What this trial is testing

Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital

Who this might be right for
Hepatitis CHepatitis BAddiction
University Hospital, Montpellier 600
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Not applicableStudy completedNCT02427204
What this trial is testing

Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality

Who this might be right for
Hepatitis C Infection
Icahn School of Medicine at Mount Sinai 150
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Large-scale testing (Phase 3)Study completedNCT00308048
What this trial is testing

14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response

Who this might be right for
Hepatitis C Virus Infection
Ullevaal University Hospital 435
Large-scale testing (Phase 3)Study completedNCT00039871
What this trial is testing

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Who this might be right for
HepatitisHepatitis C, ChronicFibrosis+1 more
Merck Sharp & Dohme LLC 2,333
Testing effectiveness (Phase 2)Study completedNCT00088504
What this trial is testing

Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis CHepatitis
Vertex Pharmaceuticals Incorporated 315
Testing effectiveness (Phase 2)Study completedNCT01306617
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C InfectionHepatitis CHepatitis C Virus
AbbVie (prior sponsor, Abbott) 50
Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Post-approval studies (Phase 4)Study completedNCT00275548
What this trial is testing

Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C

Who this might be right for
Liver TransplantHepatitis C
Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Testing effectiveness (Phase 2)Study completedNCT00227435
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT02673489
What this trial is testing

Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT04042740
What this trial is testing

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Who this might be right for
Hepatitis C InfectionHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 45
Large-scale testing (Phase 3)Study completedNCT01903278
What this trial is testing

Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Beijing Kawin Technology Share-Holding Co., Ltd. 719
Early research (Phase 1)Study completedNCT01591668
What this trial is testing

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Gilead Sciences 51
Next Page